PUBLICATIONS

16. LOGAN, R., WILLIAMS, B.G., DA SILVA, M.F., INDANI, A., SCHCOLNICOV, N., GANGULY, A., MILLER, S.J. (2021) DEEP CONVOLUTIONAL NEURAL NETWORKS WITH ENSEMBLE LEARNING AND GENERATIVE ADVERSARIAL NETWORKS FOR ALZHEIMER’S DISEASE IMAGE DATA CLASSIFICATION. FRONTIERS IN AGING NEUROSCIENCE, 13, 497

15. PETERS, O. M., WEISS, A., METTERVILLE, J., SONG, L., LOGAN, R., SMITH, G. A., ... & FREEMAN, M. (2021). GENETIC DIVERSITY OF AXON DEGENERATIVE MECHANISMS IN MODELS OF PARKINSON'S DISEASE. NEUROBIOLOGY OF DISEASE, 155, 105368.

14. KONG, F. Z., WANG, Y., WANG, M. X., CHENG, Q. Z., LOGAN, R., WU, G. H., & HU, S. M. (2020). CLINICAL CHARACTERISTICS OF THE FIRST KNOWN CASES OF DEATH CAUSED BY COVID-19 PNEUMONIA. AGING (ALBANY NY), 12(22), 22405.

13. ANNIS, S., FLEISCHMANN, Z., LOGAN, R., MULLIN-BERNSTEIN, Z., FRANCO, M., SAÜRICH, J., ... & KHRAPKO, K. (2020). LUCS: A HIGH-RESOLUTION NUCLEIC ACID SEQUENCING TOOL FOR ACCURATE LONG-READ ANALYSIS OF INDIVIDUAL DNA MOLECULES. AGING (ALBANY NY), 12(8), 7603.

12. SCHWARZSCHILD, M. A., MACKLIN, E. A., BAKSHI, R., BATTACHARYYA, S., LOGAN, R., ESPAY, A. J., ... & PARKINSON STUDY GROUP SURE-PD INVESTIGATORS. (2019). SEX DIFFERENCES BY DESIGN AND OUTCOME IN THE SAFETY OF URATE ELEVATION IN PD (SURE-PD) TRIAL. NEUROLOGY, 93(14), E1328-E1338.

11. KASTANENKA, K. V., CALVO-RODRIGUEZ, M., HOU, S. S., ZHOU, H., TAKEDA, S., ARBEL-ORNATH, M., ... & BACSKAI, B. J. (2019). FREQUENCY-DEPENDENT EXACERBATION OF ALZHEIMER’S DISEASE NEUROPATHOPHYSIOLOGY. SCIENTIFIC REPORTS, 9(1), 1-13.

10. BAKSHI, R., MACKLIN, E. A., LOGAN, R., ZORLU, M. M., XIA, N., CROTTY, G. F., ... & SCHWARZSCHILD, M. A. (2019). HIGHER URATE IN LRRK2 MUTATION CARRIERS RESISTANT TO PARKINSON DISEASE. ANNALS OF NEUROLOGY, 85(4), 593-599.

9. CHEN, X., UMEH, C. C., TAINSH, R. E., FENG, D. D., MAGUIRE, M., ZUO, F., ... & PARKINSON STUDY GROUP. (2018). DISSOCIATION BETWEEN URATE AND BLOOD PRESSURE IN MICE AND IN PEOPLE WITH EARLY PARKINSON'S DISEASE. EBIOMEDICINE, 37, 259-268.

8. CHEN, X., CHEN, H., CAI, W., MAGUIRE, M., YA, B., ZUO, F., ... & SCHWARZSCHILD, M. A. (2017). THE MELANOMA‐LINKED “REDHEAD” MC1R INFLUENCES DOPAMINERGIC NEURON SURVIVAL. ANNALS OF NEUROLOGY, 81(3), 395-406.

7. KASTANENKA, K. V., HOU, S. S., SHAKERDGE, N., LOGAN, R., FENG, D., WEGMANN, S., ... & BACSKAI, B. J. (2017). OPTOGENETIC RESTORATION OF DISRUPTED SLOW OSCILLATIONS HALTS AMYLOID DEPOSITION AND RESTORES CALCIUM HOMEOSTASIS IN AN ANIMAL MODEL OF ALZHEIMER’S DISEASE. PLOS ONE, 12(1), E0170275.

6. BHATTACHARYYA, S., BAKSHI, R., LOGAN, R., ASCHERIO, A., MACKLIN, E. A., & SCHWARZSCHILD, M. A. (2016). ORAL INOSINE PERSISTENTLY ELEVATES PLASMA ANTIOXIDANT CAPACITY IN PARKINSON'S DISEASE. MOVEMENT DISORDERS, 31(3), 417-421.

5. BAKSHI, R., LOGAN, R., & SCHWARZSCHILD, M. A. (2015). PURINES IN PARKINSON’S: ADENOSINE A2A RECEPTORS AND URATE AS TARGETS FOR NEUROPROTECTION. IN THE ADENOSINERGIC SYSTEM (PP. 101-126). SPRINGER, CHAM.

4. BAKSHI, R., ZHANG, H., LOGAN, R., JOSHI, I., XU, Y., CHEN, X., & SCHWARZSCHILD, M. A. (2015). NEUROPROTECTIVE EFFECTS OF URATE ARE MEDIATED BY AUGMENTING ASTROCYTIC GLUTATHIONE SYNTHESIS AND RELEASE. NEUROBIOLOGY OF DISEASE, 82, 574-579.

3. SCHWARZSCHILD, M. A., ASCHERIO, A., BEAL, M. F., CUDKOWICZ, M. E., CURHAN, G. C., HARE, J. M., ... & PARKINSON STUDY GROUP SURE-PD INVESTIGATORS. (2014). INOSINE TO INCREASE SERUM AND CEREBROSPINAL FLUID URATE IN PARKINSON DISEASE: A RANDOMIZED CLINICAL TRIAL. JAMA NEUROLOGY, 71(2), 141-150.

2. CHEN, X., BURDETT, T. C., DESJARDINS, C. A., LOGAN, R., CIPRIANI, S., XU, Y., & SCHWARZSCHILD, M. A. (2013). DISRUPTED AND TRANSGENIC URATE OXIDASE ALTER URATE AND DOPAMINERGIC NEURODEGENERATION. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, 110(1), 300-305.

1. BURDETT, T. C., DESJARDINS, C. A., LOGAN, R., MCFARLAND, N. R., CHEN, X., & SCHWARZSCHILD, M. A. (2013). EFFICIENT DETERMINATION OF PURINE METABOLITES IN BRAIN TISSUE AND SERUM BY HIGH‐PERFORMANCE LIQUID CHROMATOGRAPHY WITH ELECTROCHEMICAL AND UV DETECTION. BIOMEDICAL CHROMATOGRAPHY, 27(1), 122-129.